The emerging era of personalized medicine in advanced colorectal cancer.

Wu, Claudia W K; Reid, Madeleine; Leedham, Simon; Lui, Rashid N

Wu, Claudia W K; Reid, Madeleine; Leedham, Simon; Lui, Rashid N.

Afiliación

Wu CWK; Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.
Reid M; Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, China.
Leedham S; Translational Gastroenterology Unit, John Radcliffe hospital, University of Oxford, Oxford, UK.
Lui RN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

J Gastroenterol Hepatol ; 37(8): 1411-1425, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35815339

Asunto(s)

Neoplasias Colorrectales; Medicina de Precisión; Biomarcadores de Tumor/genética; Transformación Celular Neoplásica; Neoplasias Colorrectales/tratamiento farmacológico; Neoplasias Colorrectales/genética; Humanos; Medicina de Precisión/métodos; Microambiente Tumoral/genética

Palabras clave

chemotherapy; colorectal cancer; immune checkpoint inhibition; personalized medicine; precision oncology; signaling pathway; targeted therapy; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Medicina de Precisión Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google